Latest DEF 14A proxy statements

NASDAQ
Bowen Acquisition Corp. seeks shareholder approval to extend its business combination deadline to June 14, 2026, to finalize its merger with Shenzhen Qianzhi BioTechnology Co. Ltd.
Lynx1 Master Fund LP, Neuphoria's largest shareholder, is soliciting proxies to elect two independent directors to the Board following the company's failed Phase 3 trial and subsequent dilutive share issuance.
Exact Sciences announced an agreement to be acquired by Abbott, a move expected to close in Q2 2026, aiming to expand patient reach and accelerate cancer diagnostics.
NASDAQ
SUNation Energy, Inc. calls its 2025 Annual Meeting to vote on director election, auditor ratification, and a significant amendment to its equity incentive plan, including an evergreen provision, against a backdrop of substantial financial losses and a 'going concern' warning.
NASDAQ
Palo Alto Networks, Inc. announced additional equity awards totaling over 2.7 million shares and provided an update on its equity compensation plans.
NASDAQ
Plug Power Inc. will hold a Special Meeting on January 15, 2026, to seek stockholder approval for increasing its authorized common stock and amending its charter.
NYSE
Enviri Corporation announced a definitive agreement to sell its Clean Earth division to Veolia Environnement S.A. and appointed Russell Hochman as President and COO, effective immediately.
NYSE
Enviri Corporation announced a definitive agreement to sell its Clean Earth division to Veolia Environnement S.A., pending regulatory approval.
NASDAQ
iSpecimen Inc. announces its 2025 Annual Meeting of Stockholders to vote on director elections, auditor ratification, and a new 2025 Stock Incentive Plan.
NYSE
Enviri Corporation published a LinkedIn post on November 21, 2025, regarding the proposed sale of its Clean Earth business to Veolia Environnement S.A.
The ODP Corporation filed supplemental disclosures to its definitive proxy statement in response to shareholder lawsuits alleging misleading information regarding its proposed merger with ACR Ocean Resources LLC.
OTC.Pink
Enlightify Inc. is seeking shareholder approval for a significant equity incentive plan amendment, a large common stock issuance, and a reverse stock split at its upcoming Annual Meeting.
Newton Golf Company, Inc. calls its 2025 Annual Meeting to elect directors, ratify auditors, and approve an amended equity incentive plan, while addressing Nasdaq compliance issues.
NASDAQ
Zscaler, Inc. announces its Fiscal 2025 Annual Meeting of Stockholders to be held on January 12, 2026, outlining key proposals including director elections and executive compensation votes.
NASDAQ
Zscaler's latest proxy statement highlights robust fiscal year 2025 financial performance, including significant revenue and billings growth, ahead of its virtual annual stockholder meeting.
NYSE
Sound Point Meridian Capital, Inc. announces its 2025 Annual Meeting of Stockholders to elect two directors and review corporate governance.
NASDAQ
Fossil Group, Inc. announces its 2025 Annual Meeting of Stockholders to address director elections, executive compensation, and auditor ratification, alongside significant board and executive leadership changes.
NYSE
Enviri Corporation announces the sale of its Clean Earth business to Veolia for $3.04 billion in cash and a taxable spin-off of its Harsco Environmental and Rail businesses to shareholders, who will receive $14.50-$16.50 per share plus stock in the new entity.
NYSE
Lindsay Corporation reports record net earnings and EPS for fiscal 2025, driven by international irrigation growth and infrastructure margin expansion, while announcing executive transitions and a new $150 million share repurchase program.
Repare Therapeutics announced significant shareholder support, totaling approximately 40% of outstanding shares, for its proposed acquisition by XenoTherapeutics, Inc.
Exact Sciences CEO Kevin Conroy discusses the strategic benefits of the proposed acquisition by Abbott Laboratories, emphasizing global reach and shared values.
NYSE
Shutterstock's latest proxy statement reveals 2024 financial results, executive compensation, and updates on its pending merger with Getty Images.
NYSE
Semrush Holdings, Inc. files a definitive additional proxy statement regarding its proposed merger with Fenway Merger Sub, Inc., a wholly-owned subsidiary of Adobe, Inc.
Exact Sciences Corporation has filed definitive additional materials with the SEC regarding its proposed acquisition by Abbott Laboratories, urging stockholders to review the proxy statement.
Exact Sciences Corporation announced its agreement to be acquired by global healthcare leader Abbott, with the transaction expected to close in the second quarter of 2026.
Exact Sciences announced an agreement to be acquired by Abbott for $23 billion, forming the foundation of Abbott's future in cancer diagnostics and genetics.
Exact Sciences Corporation announced its acquisition by Abbott Laboratories for $23 billion, aiming to create a leading global cancer diagnostics provider.
NASDAQ
Electronic Arts shareholders are invited to vote on a $210.00 per share all-cash acquisition by a consortium including The Public Investment Fund, Silver Lake, and Affinity Partners.
NASDAQ
Novartis AG will acquire Avidity Biosciences' neuroscience pipeline and RNA platform, while Avidity's early-stage cardiology programs will be spun off into a new independent company.
New Era Energy & Digital, Inc. announces its Annual Meeting of Stockholders on December 16, 2025, to vote on director elections, auditor ratification, and meeting adjournment.